openPR Logo
Press release

Competitive Landscape for PRP Market Key Trends 2024

01-05-2017 03:12 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Global Platelet Rich Plasma (PRP) Market: Snapshot

Of late, the global market for platelet rich plasma (PRP) has been witnessing a remarkable rise in its valuation. The upswing in the incidence of orthopedic diseases, propelled by the increasing cases of sports injuries, and the growing prevalence of cardiothoracic and neurological disorders has emerged as the main factor behind this tremendous growth of this market.

In addition to this, the surge in cosmetic surgeries and the rising awareness level of people regarding the benefits of PRP are likely to boost this market significantly in the near future. Researchers expect the opportunity in the worldwide market for PRP to increase from US$160.0 mn in 2015 to US$451.9 mn by 2024, expanding at a CAGR of 12.50% between 2016 and 2024.

P-PRF Segment to Witness Fast-paced Growth

Pure-platelet rich plasma (P-PRP), pure-platelet-rich fibrin (P-PRF), and leukocyte-platelet rich plasma (L-PRP) are the key products available in the global PRP market. Among these, the consumption of P-PRP is higher than other products. The P-PRP segment led the overall consumption of PRP across the world with a share of more than 60% in 2015. The rich content of platelets and the conventional type of PRP present in P-PRP are the key factor behind its high demand.

Download Exclusive Global Strategic Business Report:

While the P-PRP segment is likely to remain leading the global demand for PRP over the next few years, the P-PRF segment is estimated to register the growth at a faster pace during the forecast period. The presence of a large number of stem cells and leukocytes in P-PRF, together with its high efficiency, is anticipated to boost this segment substantially in the near future.

North America to Retain Dominance

The worldwide market for PRP is spread across Latin America, Europe, the Middle East and Africa, and Asia Pacific. In 2015, North America led the global market with a share of more than 45%. The rising prevalence of orthopedic diseases, sports injuries, advanced health care facilities, and improved diagnostic technologies boosted the North America PRP market significantly. Going forward, the high adoption rate of the PRP products is expected to ensure the dominance of this regional market throughout the forecast period.

Europe, which emerged second in the overall market in 2015, is anticipated to retain its position in the coming years, thanks to the rising applications of the PRP products in cosmetic procedures and for the treatment of various orthopedic diseases. Asia Pacific, on the other hand, is expected to witness a phenomenal pace of growth over the next few years. The rise in the geriatric population and the fast-developing cosmetic surgery industry are likely to drive the Asia Pacific region market for PRP in the coming years.

At the forefront of the global PRP market are Regen Lab SA, Exactech Inc., Nuo Therapeutics, Emcyte Corp., Cesca Therapeutics Inc., ISTO Biologics, AdiStem Ltd., Stryker Corp., DePuy Synthes Inc., Zimmer Biomet, Arthrex Inc., and Harvest Technologies Corp.

Browse Full Research Report on Platelet Rich Plasma (PRP) Market:

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.


Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Browse market research blog:

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Competitive Landscape for PRP Market Key Trends 2024 here

News-ID: 406243 • Views: 701

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases

More Releases for PRP

Latest Study on Platelet Rich Plasma (PRP) Market Future Growth Predictions and …
The Global Platelet Rich Plasma (PRP) Market 2019-2026 increase in the number of orthopedic surgeries and sports injuries and rise in the number of cosmetic surgeries are driving the growth of the market. However, high cost of devices & therapy will limit the market growth. The Global Platelet Rich Plasma (PRP) Market 2019 report includes Platelet Rich Plasma (PRP) Market Revenue, market Share, industry volume, and Trends, Growth aspects. Growing prevalence
Platelet Rich Plasma (PRP) Market is expected to grow at a CAGR of roughly 13.3% …
New Study Report On "Platelet Rich Plasma (PRP) Market is expected to grow at a CAGR of roughly 13.3% | Analysis By PRP Type (P-PRP, L-PRP, L-PRF), By Players (DePuy Synthes, Stryker...), By Surgery (Orthopedic, Cosmetic, General...) & Region, Size & Forecast To 2023" The worldwide market for Platelet Rich Plasma (PRP) is expected to grow at a CAGR of roughly 13.3% over the next five years, will reach 400 million
Platelet Rich Plasma Market By PRP Type (Pure-PRP, Leucocyte Rich PRP, Pure Plat …
Platelet rich plasma (PRP) is a portion of the plasma fraction of analogous blood, which contains platelet concentration more than standard concentration. Platelets contains bio proteins that helps in healing, tissue regeneration, and blood loss. Platelet rich plasma protein consists of three proteins, which acts as cell adhesive molecules that are fibrin, fibronectin, and vitronectin. The use of platelet rich plasma therapy is tremendously increased after 2009 due to its
Global Platelet Rich Plasma (PRP) Industry
Global Platelet Rich Plasma (PRP) Industry Global PRP market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Harvest Technologies DePuy Synthes Stryker Zimmer Biomet Arthrex Exactech Emcyte Corporation Arteriocyte Adilyfe Try Sample Report @ Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of PRP in
Platelet Rich Plasma (PRP) Market Forecast 2017-2021
Platelet rich plasma (PRP) market has witnessed appreciable growth due to a growing number of devices being FDA approved in recent years; however the therapeutics market is anticipated to have an uncertain future, even as non-approved therapeutic applications flourish. Although various platelet rich plasma isolation devices have received 510(k) clearance, platelet rich plasma has not been approved for direct injection or implant without prior mixing with the bone graft materials.
Driving eligibility stays after multispot PRP laser treatment
Multispot Panretinal Photocoagulation Spares Visual Fields Required For Driving Eligibility Valon Lasers is pleased to report that Valon Multispot Laser panretinal photocoagulation (PRP) in proliferative diabetic retinopathy spares visual fields required for driving eligibility according to a study from University College London Institute of Ophthalmology, U.K. Recently published study by Professor Michel Michaelides et al. assessed the effect of Multispot laser PRP on retinal sensitivity and visual fields required for driving